A detailed history of Madrone Advisors, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Madrone Advisors, LLC holds 23,391,915 shares of PACB stock, worth $36.7 Million. This represents 6.35% of its overall portfolio holdings.

Number of Shares
23,391,915
Previous 23,391,915 -0.0%
Holding current value
$36.7 Million
Previous $32 Billion 24.09%
% of portfolio
6.35%
Previous 5.63%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $7.89 Million - $21.2 Million
5,800,000 Added 32.97%
23,391,915 $32 Billion
Q4 2023

Feb 13, 2024

BUY
$5.97 - $10.36 $7.02 Million - $12.2 Million
1,175,982 Added 7.16%
17,591,915 $173 Billion
Q4 2022

Feb 13, 2023

BUY
$5.67 - $11.2 $93.1 Million - $184 Million
16,415,933 New
16,415,933 $134 Billion

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $353M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Madrone Advisors, LLC Portfolio

Follow Madrone Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madrone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Madrone Advisors, LLC with notifications on news.